- Lobbying
- Lobbying by Generex Biotechnology Corporation
Lobbying Relationship
Lobbyists
Lobbyists named here were listed on a filing related to this lobbying engagement. They may not be working on it now. Occasionally, a single lobbyist whose name is spelled two different ways on filings may be represented twice here.
Lobbyist | Covered positions? |
---|---|
Robert Wood | Chief of Staff to HHS Secretary See prior filing. |
Mary-Lacey Reuther | Special Asst. to CMS Administrator See prior filing. |
Morris Reid | Aide to Commerce Secretary; Aide to HUD Secretary See prior filing. |
Mary Lacey Reuther | See prior filing. |
Charles Jefferson | COS Rep. Mike Thompson; Admin Asst. Rep. |
Charles Jefferson (cont'd) | Mike Thompson; Spec. Asst. Rep. Gephardt; Asst to COS Rep. Gephardt; Staff Asst, WH Office of Leg. Affairs; Staff Asst. Rep. Gephardt |
Disclosures Filed
Once a lobbying engagement begins, the lobbyist or firm is required to file updates four times a year. Those updates sometimes change which lobbyists are involved or add new issues being discussed. When lobbyists stop working for a client, the firm is also supposed to file a report disclosing the end of the relationship.
Termination
Q2 Report
Lobbying Issues
Agencies Lobbied
Natl Institutes of Health (NIH)
Centers For Disease Control & Prevention (CDC)
Type of Issue
Registration
Issue(s) they said they’d lobby about: Provide strategic counsel and tactical planning to assist with "prosecution" of clinical and regulatory programs for prophylactic and immunotherapeutic platform synthetic vaccine technologies..
Source: Clerk of the U.S. House of Representatives and Secretary of the Senate